Holistic Works

Holistic Works is a biotechnology company focused on revolutionizing drug discovery through a holistic approach to protein-protein interactions (PPIs). The company utilizes its proprietary Holistic Discovery Platform to identify and target complex protein interfaces that were previously considered undruggable. By integrating advanced computational modeling with high-throughput screening, Holistic Works aims to develop novel small molecule therapeutics for high-need indications in oncology and immunology. Their lead programs are currently in the pre-clinical stage, targeting specific protein complexes involved in tumor growth and immune evasion.